SCHEMBL24796263

SCHEMBL24796263

CC1CC(=O)N(CCNC(=O)CSCC(=O)O)C(=O)C1

nearest known ligand 0.39

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ USP2 O75604 1/20 0.39
▸ ALDH1A1 P00352 3/20 0.38
▸ FABP3 P05413 1/20 0.38
▸ FABP4 P15090 1/20 0.38
▸ GAA P10253 1/20 0.36
▸ KMT2A Q03164 1/20 0.35
▸ L3MBTL1 Q9Y468 2/20 0.35
▸ CYP1A2 P05177 1/20 0.34
▸ CYP2C19 P33261 1/20 0.34
▸ MAPK1 P28482 1/20 0.34
▸ HPGD P15428 1/20 0.33
▸ HTT P42858 1/20 0.33
▸ SMN1; SMN2 Q16637 1/20 0.33
▸ MITF O75030 1/20 0.33
▸ KLF5 Q13887 1/20 0.33
▸ CYP2D6 P10635 1/20 0.32
▸ HIF1A Q16665 1/20 0.32
▸ LMNA P02545 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24795884 0.87 USP2 (0.37) USP2ALDH1A1FABP3FABP4GAA
SCHEMBL21389230 0.87 USP2 (0.37) USP2ALDH1A1FABP3FABP4GAA
SCHEMBL21389103 0.84 KMT2A (0.44) ALDH1A1FABP3FABP4GAAKMT2A
SCHEMBL21383860 0.84 USP2 (0.37) USP2ALDH1A1FABP3FABP4GAA
SCHEMBL21389303 0.84 USP2 (0.37) USP2ALDH1A1FABP3FABP4GAA
SCHEMBL26634661 0.84 USP2 (0.37) USP2ALDH1A1FABP3FABP4GAA
SCHEMBL24796138 0.84 HPGD (0.41) ALDH1A1GAAKMT2AL3MBTL1CYP1A2
SCHEMBL24796137 0.84 CYP1A2 (0.39) ALDH1A1KMT2ACYP1A2HTTSMN1; SMN2
SCHEMBL21389191 0.84 HPGD (0.44) USP2ALDH1A1GAAKMT2AL3MBTL1
SCHEMBL21383848 0.83 FABP3 (0.37) USP2ALDH1A1FABP3FABP4GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230357347-A1 MODULATORS OF G-PROTEIN COUPLED RECEPTORS CARMOT THERAPEUTICS, INC. 2023-11-09 — — US disclosed
US-20230357347-A1 MODULATORS OF G-PROTEIN COUPLED RECEPTORS CARMOT THERAPEUTICS, INC. 2023-11-09 — — US disclosed
US-11535660-B1 Modulators of G-protein coupled receptors Cannot Therapeutics, Inc. (US) 2022-12-27 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230357347-A1 MODULATORS OF G-PROTEIN COUPLED RECEPTORS GIPR, GLP1R, GCGR USP2 2595/4885ALDH1A1 3305/4885FABP3 666/4885
US-11535660-B1 Modulators of G-protein coupled receptors GIPR, GLP1R, GCGR USP2 2718/4885ALDH1A1 3367/4885FABP3 669/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback